Advertisement

Is ‘Group and Save’ Blood Request Routinely Required for Nasopharyngeal Biopsy?

  • Foster Tochukwu OrjiEmail author
  • Nekwu E. Okolugbo
Original Article

Abstract

Objectives To establish our current practice of ‘group and save’ blood for nasopharyngeal tumour biopsy (NB), and to determine the rate of blood transfusions among patients who underwent NB under general anaesthesia. Methods A retrospective chart review of all patients who underwent biopsy of NB in our tertiary institution between January 2006 and December 2015 was undertaken. Those with Juvenile nasopharyngeal angiofibroma were excluded. Data retrieved included patients’ characteristics such as age/sex, anaemia, primary tumour extension, and histology. Outcome measures included rate of ‘group and save blood’ requests, intra-operative blood loss, blood transfusion rates. Comparison was made between those that were requested to group and save blood prior to surgery (group ‘A’) and the group ‘B’ that were not so requested. Results We analysed eligible 103 cases (71 males and 32 females) out of 121 nasopharyngeal biopsies over the study period. ‘Group and save’ blood was undertaken in 47.6% (49/103) of our patients. Only 12.2% of the requested blood was transfused. Among evaluated patient characteristics, only oropharyngeal tumour extension differ between the study groups (P = 0.025). Overall, 14% had significant intra-operative blood loss (>500 ml), while 9.7% were transfused. The rates of blood loss and transfusion were not significantly different between the study groups (P = 0.22 and 0.09 respectively). Significant factors that influenced transfusion were pre-operative anaemia and oropharyngeal tumour extension. Conclusion There was high rate of arbitrary request for ‘group and save blood’ prior to NB in our institution over the last decade, which seems largely unnecessary. We recommend it be undertaken only in the presence anaemia and extensive oropharyngeal tumour extension.

Keywords

Blood transfusion Group and cross matching Nasopharyngeal biopsy Peri-operative haemorrhage 

Notes

Compliance with Ethical Standards

Conflict of interest

None declared.

Ethical Approval

This article does not contain any studies with human participants performed by any of the authors.

References

  1. 1.
    Romani R, Tuominen H, Hernesniemi J (2010) Reducing intraoperative bleeding of juvenile nasopharyngeal angiofibroma. World Neurosug 74:497–500CrossRefGoogle Scholar
  2. 2.
    Yüce S, Uysal IO, Doğan M, Polat K, Şalk I, Müderris S (2013) A giant juvenile nasopharyngeal angiofibroma. J Craniofac Surg 24:207–209Google Scholar
  3. 3.
    Li Z, Lin C, Lin G, Fang Z (2010) Study and analysis on the hemorrhage of pterygoid venous plexus in large nasopharyngeal angiofibroma resection. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 24:244–246PubMedGoogle Scholar
  4. 4.
    da Lilly-Tariah OB, Somefun AO (2003) Malignant tumours of the nasopharynx at Jos University Teaching Hospital. Niger Postgrad Med J 10:99–102PubMedGoogle Scholar
  5. 5.
    Brugere J, Point D, Sancho-Garnier H, Schwaab G (1978) Epidemiology of malignant tumours of the nasopharynx in France: retrospective and prospective studies. IARC Sci Publ 20:241–249Google Scholar
  6. 6.
    Bove JR (1987) Transfusion-associated hepatitis and AIDS. What is the risk? N Engl J Med 317:242–245CrossRefPubMedGoogle Scholar
  7. 7.
    de Stasio G (1992) Transfusion risks and alternatives to transfusion. Recenti Prog Med 83:321–329PubMedGoogle Scholar
  8. 8.
    Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Ferraris SP et al (2007) Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg 83:S27–S86CrossRefGoogle Scholar
  9. 9.
    Rohling RG, Haers PE, Zimmermann AP, Schanz U, Marquetand R, Sailer HF (1999) Multimodal strategy for reduction of homologous transfusions in cranio-maxillofacial surgery. Int J Oral Maxillofac Surg 28:137–142CrossRefPubMedGoogle Scholar
  10. 10.
    Katz E, Gaitini L, Samri M, Egoz N, Fergusson D et al (2001) The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel. Isr Med Assoc J 3:809–812PubMedGoogle Scholar
  11. 11.
    Graham ID, Fergusson D, McAuley L, Laupacis A (2000) The use of technologies to minimize exposure to perioperative allogeneic blood transfusion in elective surgery. A survey of Canadian hospitals. Int J Technol Assess Health Care 16:228–241CrossRefPubMedGoogle Scholar

Copyright information

© Association of Otolaryngologists of India 2017

Authors and Affiliations

  1. 1.Department of OtolaryngologyUniversity of Nigeria Teaching HospitalItuku-Ozalla, EnuguNigeria
  2. 2.Department of SurgeryDelta State UniversityAbrakaNigeria

Personalised recommendations